XBP1 and metabolic dysfunction-associated steatotic liver disease: Next, to link these findings to human disease, we interrogated two human datasets of NAFLD/NASH as well as that of a high fat diet-treated mouse model of NAFLD, confirming induction of our XBP1 signature that well-correlates with the HSC activation signature in both human disease and animal model.